Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1395
TNBC
Basal B
Olomoucine II
CDK1
CDK
12000.147
uM
1.29190
5.58930
-0.7875 -1.0000 0.7500 0.5438
0.9891
0.8658
HCC1395
TNBC
Basal B
Olomoucine II
CDK1
CDK
12084.147
uM
2.45050
6.10990
-0.9226 -1.0000 1.2025 0.4911
0.9923
1.0888
HCC1395
TNBC
Basal B
Omipalisib
PI3K
PI3K
7436.086
uM
0.05410
0.10839
-0.4362 -0.3666 0.7914 0.5942
0.9890
1.2908
HCC1395
TNBC
Basal B
Omipalisib
PI3K
PI3K
7435.086
uM
0.04668
0.08962
-0.5533 -0.4697 1.0156 0.6598
0.9947
0.7985
HCC1395
TNBC
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
7814.011
uM
6.40760
18.72460
-0.9862 -1.0000 1.0245 0.5881
0.9818
0.9472
HCC1395
TNBC
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
9254.12
uM
13.53450
28.71380
-0.9973 -1.0000 1.4607 0.5367
0.9858
1.1139
HCC1395
TNBC
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
9258.011
uM
9.15040
20.36390
-0.9998 -1.0000 1.3733 0.5503
0.9911
0.6984
HCC1395
TNBC
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
7813.011
uM
15.19250
28.71610
-0.9984 -1.0000 1.7256 0.4886
0.9928
0.8718
HCC1395
TNBC
Basal B
Oxamflatin
HDAC
HDAC
12000.147
uM
2.23580
4.13130
-0.9833 -1.0000 1.7892 0.5376
0.9627
0.8658
HCC1395
TNBC
Basal B
Oxamflatin
HDAC
HDAC
12084.147
uM
1.98330
4.23350
-0.9934 -0.9984 1.4474 0.4051
0.9945
1.0888
HCC1395
TNBC
Basal B
PD 98059
MEK
MAPK
12000.159
uM
inf
inf
0.5712 0.5712 0.0000 0.2188
0.2067
0.9695
HCC1395
TNBC
Basal B
PD 98059
MEK
MAPK
12084.159
uM
inf
inf
0.7553 0.7553 0.0000 0.1165
0.3011
1.2294
HCC1395
TNBC
Basal B
PD173074
FGFR1/3
RTK
7436.093
uM
0.71193
4.33350
-0.7459 -1.0000 0.6083 0.3893
0.9663
1.2596
HCC1395
TNBC
Basal B
PD184352
MEK
MAPK
12084.155
uM
inf
inf
0.9292 0.9292 0.0000 0.0091
0.2182
1.2955
HCC1395
TNBC
Basal B
PD184352
MEK
MAPK
12084.155
uM
inf
inf
0.9292 0.9292 0.0000 0.0091
0.2182
1.2955
HCC1395
TNBC
Basal B
PD184352
MEK
MAPK
12000.155
uM
inf
0.04759
0.7096 0.6521 0.1954 0.1775
0.6664
0.8592
HCC1395
TNBC
Basal B
PD184352
MEK
MAPK
12000.155
uM
inf
0.04759
0.7096 0.6521 0.1954 0.1775
0.6664
0.8592
HCC1395
TNBC
Basal B
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7435.095
uM
inf
inf
0.8669 0.8669 0.0000 0.0762
-0.0489
0.8762
HCC1395
TNBC
Basal B
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7436.095
uM
inf
inf
0.9643 0.9643 0.0000 0.0131
0.0000
1.3597
HCC1395
TNBC
Basal B
PS-1145
IKK
NFKB
7435.065
uM
inf
inf
0.7303 0.7303 0.0000 0.1363
0.4121
0.8513
HCC1395
TNBC
Basal B
PS-1145
IKK
NFKB
7436.065
uM
inf
334.83990
0.7935 0.7935 5.0000 0.0156
0.8959
1.2177
HCC1395
TNBC
Basal B
Purvalanol A
CDK1
CDK
7436.067
uM
inf
inf
0.9747 0.9747 0.0000 0.0019
0.2592
1.2834
HCC1395
TNBC
Basal B
Purvalanol A
CDK1
CDK
7435.067
uM
inf
inf
0.6392 0.6392 0.0000 0.0374
0.2883
0.7691
HCC1395
TNBC
Basal B
QNZ
NFkB
NFKB
7436.096
uM
0.04421
0.01523
0.3122 0.3346 1.0381 0.4050
0.9728
1.3979
HCC1395
TNBC
Basal B
SB-3CT
MMP2/9
MMP
12000.168
uM
inf
inf
0.7308 0.7308 0.0000 0.1195
0.3207
0.7873